Improving Survival Trends in Primary Myelofibrosis: An International Study
Author(s) -
Francisco Cervantes,
Brigitte Dupriez,
Francesco Passamonti,
Alessandro M. Vannucchi,
Enrica Morra,
John T. Reilly,
Jean-Loup Demory,
Elisa Rumi,
Paola Guglielmelli,
Elisa Roncoroni,
Ayalew Tefferi,
Arturo Pereira
Publication year - 2012
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2012.42.0240
Subject(s) - medicine , leukocytosis , myelofibrosis , incidence (geometry) , relative risk , relative survival , constitutional symptoms , disease , pediatrics , surgery , epidemiology , confidence interval , bone marrow , cancer registry , physics , optics
Despite the lack of major improvements in the treatment of primary myelofibrosis (PMF), there are recent indications that the survival of patients might have increased over the years. This study was aimed at ascertaining whether survival prolongation has actually occurred in PMF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom